Sanofi-Aventis Expands Aureus Pharma Pact

Nov 05, 2009

NEW YORK (GenomeWeb News) – Sanofi-Aventis has extended a license agreement with Aureus Pharma for its data-management line, including its latest database tools, for three years, Aureus said today.

Paris-based Aureus said it will provide its new AurScope knowledge databases and will update its existing databases for the drug maker’s R&D programs.

The therapeutic targets in the databases include kinase inhibitors, nuclear receptors, GPCR protein receptors, and drug safety information related to absorption, distribution, metabolism, and excretion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

No Flu for These Birds

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

To Track Cholera

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Better Odds?

Vox explores a proposal to institute a lottery system to award grant funds.

This Week in Genome Biology

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.

Featured White Papers

NGS is Accelerating Therapeutic Antibody Discovery - What Lies Beyond?

Powerful Bioinformatic Support for Specialized Therapeutic Antibody Discovery

Feb

21

Featured Webinar

Case Study: 'Companion Informatics' to Automate Immunotherapy Manufacturing and Treatment

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Mar

14

Featured Webinar

A Multiomics Approach to Defining the Nature of Early Malignant Transformations of the Immune System

In this webinar, Dr. Wendy Béguelin of Weill Cornell Medicine will discuss how she used the BD Rhapsody single-cell RNA-seq platform and YFP floxed reporter mouse models to study how lymphoma-associated mutations disrupt the immune system by affecting GC B-cell states, explaining the biology of initiation of low-grade follicular lymphoma.

Main menu